Advanced Search

 

Study ID Status Title Patient Level Data
S3A-157 Completed An evaluation of the steady-state pharmacokinetics of ondansetron after 1, 4 and 8 mg oral doses
S3A-158 Completed Comparison of the pharmacokinetics of ondansetron (GR38032F) in patients with various degrees of hepatic insufficiency and in normal healthy subjects.
S3A161 Completed A randomized, double-blind, placebo-controlled study of the effects of two dose levels of intravenous ondansetron on respiratory depression induced by alfentanil in healthy male volunteers.
S3A-166 Completed An evaluation of the pharmacokinetic properties of a single intravenous dose of GR38032 in healthy, adult male volunteers
S3A-171 Completed An evaluation of the effect of dosage on the pharmacokinetics of intravenous ondansetron.
S3A172 Completed An ascending dose safety and pharmacokinetic evaluation of ondansetron administered as single intravenous bolus doses to healthy male volunteers.
S3A173 Completed A dose-proportionality study of ondansetron administered as a single intravenous dose to healthy male volunteers.
S3A174 Completed A dose-proportionality study of ondansetron administered as a single oral dose (tablet) to healthy male volunteers.
S3A176 Completed Evaluation of the Effects of Cytochrome P-450 Enzyme Inducers (Carbamazepine and Phenytoin) on Ondansetron Pharmacokinetics.
S3A179 Completed Pharmacokinetics of 16 mg ondansetron suppository, 8 mg zofran tablet, and 8 mg zofran injection in healthy adult male and female subjects.
S3A20005 Completed A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral 16MG BD Ondansetron (GR38032F) in Preventing Post-Operative Nausea and Vomiting in Patients Having General Anaesthesia and Undergoing Major Gynaecological Surgery
S3A-237 Completed Treatment of Postoperative Nausea and Vomiting: A Randomized Double-Blind Comparison of Intravenous Ondansetron and Placebo in Female Patients Undergoing Laparoscopic Procedures
S3A-241 Completed A Randomized, Double-Blind Comparison of Intravenous Ondansetron and Placebo in the Prevention of Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Procedures
S3A242 Completed A Randomized, Double-Blind Comparison of Intravenous Ondansetron and Placebo in the Prevention of Postoperative Nausea and Vomiting in Female Patients Undergoing Inpatient Surgical Procedures
S3A-243 Completed Prevention of Postoperative Nausea and Vomiting: A Randomized, Double-blind Study of Intravenous Ondansetron in Female Patients Undergoing Laparoscopic Procedures.
S3A-245 Completed Treatment of Postoperative Nausea and Vomiting: A Randomized Double-Blind Study of Intravenous Ondansetron in Patients Undergoing Surgical Procedures on an Outpatient Basis
S3A248 Completed Prevention of Postoperative Nausea and Vomiting: A Randomized Double-Blind Study of Intravenous Ondansetron in Female Patients Undergoing Surgical Procedures on an Ambulatory Basis
S3A-249 Completed A Randomized, Double-Blind, Placebo-Controlled, Study of the Effects of Intravenous Ondansetron on Atracurium-Induced Neuromuscular Blockade in Patients Undergoing Surgical Procedures
S3A-255 Completed A Double-Blind, Placebo-Controlled, Dose-Ranging Study of Intravenous Ondansetron in the Treatment of Opioid-Induced Emesis
S3A-284 Completed A Double-Blind Dose Comparison of Oral GR-C507/75 in the Prevention of Delayed Nausea and Vomiting Associated With Cisplatin
S3A-287 Completed An Open Label Evaluation of Three Different Doses of Oral GR-C507/75 In the Prevention of Nausea and Vomiting Associated with Non-Cisplatin Chemotherapy
S3A290 Completed A Randomized, Double-Blind Comparison of Intravenous GR-C507/75 (Ondansetron) and Placebo in the Treatment of Postoperative Nausea and Vomiting
S3A-291 Completed A Double-Blind Evaluation of Oral GR-38032F in the Prevention of Delayed Nausea and Vomiting Associated With High-Dose Cisplatin
S3A30020 Completed A Randomised, Double-Blind Comparison of Ondansetron Suppository and Oral Ondansetron in the Prevention of Emesis and Nausea Associated with Cyclophosphamide Chemotherapy
S3A30023 Completed A Randomised Double-Blind Study to Compare the Efficacy and Safety of Oral GR38032F with Metoclopramide in the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy Regimen(s) Containing Epirubicin and Cyclophosphamide

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.